ISSN: 2161-0460

Journal of Alzheimers Disease & Parkinsonism
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Richard Meibach

Novartis,East Hanover,Neuroscience and Ophthalmology NJ, USA

Biography

Dr . Richard C. Meibach, Ph.D., is currently the Global Head of Regulatory Affairs for Neuroscience and Ophthalmology at Novartis Pharmaceuticals. Prior to joining Novartis, Dr. Meibach had been Vice President of Clinical Science at Hoffmann-La Roche Inc., Pharmaceuticals.
Research Interest

 His research interests were in the anatomical and functional connections of the limbic and extrapyramidal systems in the brain. Major discoveries included the determination of the origin of the fornix system, localization and visualization of serotoninergic type 2 receptors in the brain, and the localization of phencylclidine (angel dust) effects on brain metabolism.

Publications
https://bahigox.fun/ https://bahisjet.fun/ https://bahsegel.fun/ https://betboo.fun/ https://betdoksan.xyz/ https://betebetgiris.xyz/ https://betexper.fun/ https://betgram.fun/ https://betkanyon.fun/ https://betkolik.fun/
Top